Breast cancer research needs more focus on environment: report
February 12, 2013 by Amanda Gardner, Healthday Reporter in Cancer
Unlike family history, risk factors such as chemical exposure, obesity can be changed, experts say.
(HealthDay)—Efforts to prevent breast cancer need to focus more aggressively and coherently on environmental factors.
That's the conclusion of a new report released Tuesday by a committee tasked in 2008 by the U.S. Congress to investigate the environment's impact on breast cancer.
Chemical and radiation exposure, drugs and consumer products are among environmental factors addressed in the report, but so are less obvious factors connected to lifestyle and socioeconomic resources.
If researchers could identify specific factors in the environment, they could take steps to remove them from the environment and/or help people avoid them, said Michael Gould, a member of the Interagency Breast Cancer and Environmental Research Coordinating Committee, which prepared the report.
"This area of primary prevention and taking things out of the environment that might reduce the amount of breast cancer is not as bold as it could be," Gould said.
Environment in this case is defined broadly to mean not just chemicals but also obesity and socioeconomic status, he added. Primary prevention refers to preventing the first onset of a disease, as opposed to a recurrence.
The 270-page report also states that more research is needed on how different populations, such as underrepresented minorities, might face higher exposures.
Issues of obesity and socioeconomic status, in particular, are "understudied and underappreciated," said Dr. Jay Brooks, chairman of hematology/oncology at Ochsner Health System in Baton Rouge, La.
Obesity is responsible for about 20 percent of all cancers, and obesity and poverty often overlap, added Brooks, who was not involved with the report.
The American Cancer Society estimates that 232,000 women will be diagnosed with invasive breast cancer in 2013 and nearly 40,000 will die of the disease.
Given that most breast cancers occur in women with no family history of the disease, environmental factors could play significantly into prevention efforts, the report stated.
The authors reviewed the existing literature on prevention of breast cancer and came up with several recommendations, the first being that the area of environment in the primary prevention of breast cancer needs better financial support.
"The committee feels the country can do better by increasing that level of support," said Gould, who is a professor of oncology at the University of Wisconsin-Madison School of Medicine and Public Health.
In tandem with more financial investment, organizations—both governmental and nongovernmental—need to work together in a more coordinated and strategic manner, the report stated.
And much more research is needed into the chemical and physical causes of breast cancer. This might include low-dose radiation or compounds known as endocrine disruptors, such as bisphenol A (BPA), which are found in manufactured plastics. (There is no clear evidence yet that BPA causes breast cancer in humans.)
"We have tens of thousands of compounds produced by the chemical industry and we haven't tested all of them," Gould said.
Animal research could play an important role in filling the research gaps, he added.
When looking at these environmental factors, scientists need to focus specifically on the times of life when the breast may be most susceptible to insult from outside forces, for example, while the fetus is still in the womb.
Finally, the dialogue around cancer prevention needs to involve the public and findings need to be carefully relayed to this community.
"It is the responsibility of scientists and the government to make sure women are informed," Gould said. "We're really advocating that lines of communication be open."
More information: For more on environmental factors and health, visit the U.S. National Institute of Environmental Health Sciences.
Health News Copyright © 2013 HealthDay. All rights reserved.
-
Men with breast cancer face high risk of second cancer
Jan 25, 2007 |
not rated yet |
0
-
Review examines breast cancer prevention strategies in the United States
Nov 05, 2008 |
not rated yet |
0
-
Breast cancer type linked to paternal cancer
Nov 28, 2011 |
not rated yet |
0
-
Many chemicals unproven to raise breast cancer risk
Dec 07, 2011 |
not rated yet |
0
-
ER/PR negative tumors associated with insurance status
Nov 18, 2008 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
How can there be a term called "intestinal metaplasia" of stomach
5 hours ago
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Racial disparities in the surgical management of non-small cell lung cancer
The surgical management of non-small cell lung cancer (NSCLC) in U.S. hospitals varies widely depending on the race of the patient, according to a new study.
Cancer
2 hours ago |
not rated yet |
0
Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency
Treatment with an Alpha-1 proteinase inhibitor (A1-PI), a naturally occurring protein that protects lung tissue from breakdown and protects the lung's elasticity, is effective in slowing the progression of emphysema in patients ...
Cancer
2 hours ago |
not rated yet |
0
New tumour-killer shows great promise in suppressing cancers
Scientists from Nanyang Technological University (NTU) and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells.
Cancer
2 hours ago |
5 / 5 (1) |
0
New factor to control oncogene-induced senescence
An article published on the journal Nature describes the major role that Pyruvate dehydrogenase (PDH) —an enzyme of cellular energy metabolism— plays in the regulation of the cellular senescence induce ...
Cancer
3 hours ago |
not rated yet |
0
Anti-CD47 antibody may offer new route to successful cancer vaccination
(Medical Xpress)—Scientists at the School of Medicine have shown that their previously identified therapeutic approach to fight cancer via immune cells called macrophages also prompts the disease-fighting killer T cells ...
Cancer
4 hours ago |
not rated yet |
0
|
If you can remember it, you can remember it wrong
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
Insight into the dazzling impact of insulin in cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
Estimates reveal low population immunity to new bird flu virus H7N9 in humans
The level of immunity to the recently circulating H7N9 influenza virus in an urban and rural population in Vietnam is very low, according to the first population level study to examine human immunity to the virus, which was ...
Finding a family for a pair of orphan receptors in the brain
Researchers at Emory University have identified a protein that stimulates a pair of "orphan receptors" found in the brain, solving a long-standing biological puzzle and possibly leading to future treatments for neurological ...
Study finds vitamin C can kill drug-resistant TB (w/ video)
In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding ...
Glaucoma drug can cause droopy eyelids
Prostaglandin analogues (PGAs), drugs which lower intraocular pressure, are often the first line of treatment for people with glaucoma, but their use is not without risks. PGAs have long been associated with blurred vision, ...